Identification of Serum CMTM2 as a Potential Biomarker for HBV-Related Disorders

Figure 2

Correlation between serum levels of CMTM2 and HBV DNA load. Distribution of serum CMTM2 in CHB (a), HBLC and HCC (b) patients with low or high viral load (<6 and ≥6 log10 IU/ml). Correlation between serum CMTM2 and HBV DNA load in CHB (c), HBLC and HCC(d) patients. Data represents the mean ± SD, p <0.01; NS: no statistical significance.

(a)

(b)

(c)

(d)